Christina Applegate’s Misdiagnosis Highlights Challenges in MS Diagnosis
The actress’s recent revelation that she does not have multiple sclerosis underscores the difficulties doctors face in accurately diagnosing the complex neurological condition.
Actress Christina Applegate, who publicly shared her multiple sclerosis diagnosis in 2021, recently revealed that she no longer has the condition and that doctors are still uncertain about the cause of her symptoms. This situation highlights the persistent challenges in diagnosing multiple sclerosis (MS), a condition that affects an estimated 1 million Americans.
The Complexity of Diagnosing MS
Multiple sclerosis is an autoimmune disease where the body's immune system mistakenly attacks the protective myelin sheath around nerves in the brain and spinal cord. This damage disrupts nerve signals, leading to a range of symptoms including motor impairment, tingling sensations, and vision problems. The disease can manifest in different ways, with some individuals experiencing relapses and remissions, while others face a progressive decline.
Experts point to several factors that make MS diagnosis difficult. The exact cause of MS remains unknown, although risk factors like smoking, obesity, and genetics are recognized. "We don’t really know what causes or triggers the autoimmune response in any given individual," said Dr. Andrew Solomon, a neurologist specializing in MS at the University of Vermont.
Furthermore, there is no single definitive test for MS. Diagnosis typically involves MRI scans to detect lesions characteristic of the disease, but these scans can be misinterpreted. Other rare conditions and cerebrovascular diseases can mimic MS on imaging. Spinal fluid analysis can reveal immune system abnormalities common in MS patients, but it is not a standalone diagnostic tool.
Early symptoms of MS, such as fatigue, brain fog, or general malaise, can be vague and easily dismissed, especially if they are temporary. "Neurological symptoms sometimes can be vague — numbness, pins and needles — and it’s usually short-lived," explained Dr. Saud Sadiq, director of the Tisch Multiple Sclerosis Research Center of New York. "Unless they’re taken seriously initially, they may be ignored because by the time the patient goes through the healthcare system and is actually referred to a neurologist, the symptoms have abated."
A meta-analysis suggests that approximately 15 percent of MS diagnoses may be false positives. One study found that 40 percent of individuals later diagnosed with MS were initially misdiagnosed with a different condition.
Pressure to Diagnose and Evolving Criteria
The heterogeneous nature of MS, meaning it presents differently in each person and varies in severity, contributes to diagnostic challenges. According to Dr. Solomon, the pressure to provide a diagnosis, especially with the availability of effective early treatments, can sometimes lead clinicians to diagnose MS prematurely, even if diagnostic criteria are not fully met. "There may be a lot of clinicians who, if they can’t find a better explanation than MS, may be inclined to diagnose MS, even if they don’t really meet our diagnostic criteria, because they’re worried about missing a window of opportunity to treat somebody," he stated.
However, there is progress. The National Multiple Sclerosis Society released updated diagnostic criteria in 2024, which are intended to help physicians better distinguish MS from conditions like migraines or vascular disease. The potential of artificial intelligence in analyzing medical images also offers hope for improved diagnostic accuracy.
Patient Advocacy and Diagnosis Confidence
Despite the diagnostic complexities, MS is considered a treatable condition. "The prognosis with new drugs is extremely good for long-term care," Dr. Sadiq noted. "If patients stick to treatment at a good MS center, you can look forward to a life without disability."
Experts advise patients to be vigilant about symptoms. Persistent numbness or tingling lasting more than 24 to 48 hours, motor difficulties, or specific patterns of vision loss warrant medical attention. Dr. Annette Langer-Gould of Kaiser Permanente emphasized the importance of having MRI scans reviewed by MS specialists and highlighted the value of spinal fluid tests for diagnostic certainty.
Patients are encouraged to be their own advocates. If diagnosed with MS, asking doctors about the specific evidence is crucial. Seeking a second opinion from a recognized MS center is also recommended. For those already diagnosed, a direct conversation with their physician about how their case met diagnostic criteria can provide reassurance. "For many people, the diagnosis actually can be very straightforward," Dr. Solomon said. "We really have no question about what it is."